Leishmania parasites possess a platelet-activating factor acetylhydrolase important for virulence

被引:22
|
作者
Pawlowic, Mattie C. [1 ]
Zhang, Kai [1 ]
机构
[1] Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA
关键词
Phospholipase; Virulence; Leishmania; Platelet-activating factor; PAF-AH; Macrophage; INDEPENDENT PHOSPHOLIPASE A(2); TRYPANOSOMA-BRUCEI; AMAZONENSIS INFECTION; TOXOPLASMA-GONDII; INTERFERON-GAMMA; GLYCOINOSITOL PHOSPHOLIPIDS; PARASITOPHOROUS VACUOLES; MOLECULAR-CLONING; ARACHIDONIC-ACID; LIPOPHOSPHOGLYCAN;
D O I
10.1016/j.molbiopara.2012.08.005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Leishmania parasites are intracellular protozoans capable of salvaging and remodeling lipids from the host. To understand the role of lipid metabolism in Leishmania virulence, it is necessary to characterize the enzymes involved in the uptake and turnover of phospholipids. This study focuses on a putative phospholipase A2 (PLA2)/platelet-activating factor acetylhydrolase (PAF-AH) in Leishmania major. In mammals, PAF-AH is a subgroup of PLA2 catalyzing the hydrolysis/inactivation of platelet-activating factor (PAF), a potent mediator of many leukocyte functions. By immunofluorescence microscopy. L major PLA2/PAF-AH is predominantly localized in the ER. While wild type L. major parasites are able to hydrolyze PAF, this activity is completely absent in the PLA2/PAF-AH-null mutants. Meanwhile, deletion of PLA2/PAF-AH had no significant effect on the turnover of common glycerophospholipids such as phosphatidylcholine, phosphatidylethanolamine. phosphatidylserine, and phosphatidylglycerol. PLA2/PAF-AH is not required for the growth of L major parasites in culture, or the production of GPI-anchored virulence factors. Nonetheless, it does play a key role in the mammalian host as the PLA2/PAF-AH null mutants exhibit attenuated virulence in BALB/c mice. In conclusion, these data suggest that Leishmania parasites possess a functional PAF-AH and the degradation of PAF or PAF-like lipids is an important step in infection. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:11 / 20
页数:10
相关论文
共 50 条
  • [41] Methods of detecting lesions in the platelet-activating factor acetylhydrolase gene
    Cousens, Lawrence S.
    Eberhardt, Christine D.
    Gray, Patrick
    Trong, Hai L.
    Tjoelker, Larry W.
    Wilder, Cheryl L.
    Biotechnology Advances, 1997, 15 (3-4):
  • [42] Activated mast cells release extracellular type platelet-activating factor acetylhydrolase that contributes to autocrine inactivation of platelet-activating factor
    Nakajima, K
    Murakami, M
    Yanoshita, R
    Samejima, Y
    Karasawa, K
    Setaka, M
    Nojima, S
    Kudo, I
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (32) : 19708 - 19713
  • [43] Estrogen effects on platelet-activating factor and platelet-activating factor acetylhydrolase activity in rat uterus during the late stages of pregnancy
    Li, L
    Yasuda, K
    Matsubara, T
    Okada, H
    Nakajima, T
    Sanezumi, M
    Kanzaki, H
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 1999, 57 (04): : 219 - 230
  • [44] Cloning, expression and antibody production of caprine platelet-activating factor acetylhydrolase
    Tsao, P. H.
    Kuo, T. Y.
    Hsu, J. T.
    Chow, L. P.
    Wu, F. Y.
    JOURNAL OF ANIMAL SCIENCE, 2007, 85 : 277 - 277
  • [45] Plasma platelet-activating factor acetylhydrolase activity in critically ill patients
    Claus, RA
    Russwurm, S
    Dohrn, B
    Bauer, M
    Lösche, W
    CRITICAL CARE MEDICINE, 2005, 33 (06) : 1416 - 1419
  • [46] Inhibition of Platelet-activating Factor Acetylhydrolase Activity by Oxidants. † 1541
    Amy N MacRitchie
    Kun Qu
    Diana M Stafforini
    Thomas M McIntyre
    Guy A Zimmerman
    Stephen M Prescott
    Pediatric Research, 1997, 41 (Suppl 4) : 259 - 259
  • [47] Serum paraoxonase and platelet-activating factor acetylhydrolase in chronic renal failure
    Hasselwander, O
    McMaster, D
    Fogarty, DG
    Maxwell, AP
    Nicholls, DP
    Young, IS
    CLINICAL CHEMISTRY, 1998, 44 (01) : 179 - 181
  • [48] Plasma platelet-activating factor acetylhydrolase deficiency in Japanese patients with asthma
    Satoh, N
    Asano, K
    Naoki, K
    Fukunaga, K
    Iwata, M
    Kanazawa, M
    Yamaguchi, K
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : 974 - 979
  • [49] Serum platelet-activating factor acetylhydrolase activity in patients with atopic dermatitis
    Ohnishi, T
    Watanabe, S
    Kobayashi, M
    Sugimoto, M
    Yamada, K
    Yamaoka, K
    Kinoshita, M
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2003, 33 (01) : 70 - 72
  • [50] The significance of serum platelet-activating factor acetylhydrolase in systemic lupus erythematosus
    Tanaseanu, S
    Tanaseanu, C
    Moldoveanu, E
    Kosaka, T
    Manea, G
    Badea, C
    Diaconu, C
    Marta, D
    Cojan, A
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 234 - 234